kTMP-Enhanced Arm Rehabilitation in Chronic Stroke (KULMINATE) Pilot
Official title: kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery
Run by Magnetic Tides · NCT07631078 · Data updated 2026-11-12
This pilot tests whether kTMP, a gentle brain stimulation method, can help improve arm and hand movement in adults with chronic stroke.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 6 (estimated) |
| Sponsor | Magnetic Tides Industry-sponsored |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | October 1, 2026 |
| Main results expected | February 28, 2027 |
| Study ends | August 2028 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT07631078 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18-80 years with a history of ischemic or hemorrhagic stroke at least 12 months prior and a baseline FMA-UE score of 20-50, who can follow commands and show detectable motor-evoked potentials.
✕Probably not a fit
Patients without adequate motor-evoked potentials, significant cognitive or language impairments, or uncontrolled medical conditions may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a 6-week, double-blind, randomized, sham-controlled pilot study. Participants with chronic stroke who have moderate arm weakness will be assigned to either kTMP plus simple motor tasks or sham kTMP with the same tasks. The study measures upper-limb movement outcomes at the end of treatment and during follow-up up to 6 months. Randomization occurs within one week of starting treatment, with sessions delivered three times per week. Outcomes include kinematic measures such as range of motion in the arm, hand, and fingers.
Why it matters
Potential benefit: If successful, participants may experience improved upper-limb function and greater potential for daily activities.
How similar studies have gone: Prior studies in similar neuromodulation approaches have shown feasibility and signals of benefit in motor recovery, but this exact kTMP approach is exploratory in chronic stroke.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: 1. Adults aged 18-80 years who have a history of an ischemic or hemorrhagic stroke ≥ 12 m prior to enrollment. 2. Fugl-Meyer Assessment: Upper Extremity (FMA UE) score 20-50. 3. Ability to communicate, understand, and give appropriate consent. Participants can follow two-step commands. 4. Motor evoked potentials in a hand muscle when stimulating ipsilesional cortex with suprathreshold single-pulse TMS (MEP positive). Exclusion criteria: 1. Participants with moderate or severe cognitive impairment (MMSE \< 18). 2. Participants with sensory deficits FMA-S \< 6/12 (with proprioception \< 4/8). 3. Participants with severe apraxia (TULIA \< 5). 4. Language impairment or behavioral disorder that interferes with their ability to adhere to the protocol or to provide informed consent. 5. Individuals who have a serious uncontrolled medical condition, including but not limited to severe cardiovascular and cardiopulmonary disease. 6. Pregnancy or plans to become pregnant during the study period. 7. Botulinum toxin injections of the affected upper extremity within 3 months prior to onset of study. 8. Severe spasticity of the affected upper limb (Modified Ashworth ≥ 4). 9. Absolute contraindications related to non-invasive brain stimulation, including: 9a) History of seizures in the last 12 months while taking anti-epilepsy medication 9b) Presence of any metal implants in the head (excluding the mouth), such as cortical stimulators and DBS, clips, coils, shunts, stents or skull plates, cochlear implants 9c) Permanent eye liner or head tattoos 9d) Implanted electronics such as pacemakers, defibrillators, intrathecal baclofen pumps or vagus nerve stimulator 9e) History of experiencing a serious adverse event during a previous transcranial magnetic stimulation (TMS) session
Where it's running
-
UCSF Mission Bay- Sandler Neurosciences Center
San Francisco, California, United States Recruiting
Study contacts
- Study coordinator: Ludovica Labruna, PhD
- Email: participate@magnetictides.com
- Phone: 5104237125
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using patterned non-invasive brain stimulation (iTBS) to improve hand strength after chronic stroke
This trial will test whether a high-dose patterned non-invasive brain stimulation (iTBS) can help people with chronic stroke regain hand muscle strength and motor control.
-
Optimizing low-intensity focused ultrasound to improve arm movement after stroke
This research will try low-intensity focused ultrasound on the motor cortex to see if different power levels and timing improve arm strength and motor learning in people at least six months after a first stroke.
-
Intermittent Theta Burst Stimulation (iTBS) to improve upper‑limb movement after chronic stroke
This study will test if brief non‑invasive brain stimulation (iTBS) applied to the affected motor cortex plus regular physical therapy can improve arm and hand movement in adults who had a stroke more than six months earlier.
-
Intermittent Theta Burst Stimulation for lower limb recovery after chronic stroke
This trial tests whether intermittent Theta Burst Stimulation (iTBS) of the cerebellum, combined with physical therapy, can improve leg movement and walking in people with chronic stroke.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Digital rehabilitation system for stroke recovery
This study is testing a smartphone app that uses virtual and augmented reality to help stroke patients recover at home and see if it works better than regular therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.